Litcius/Paper detail

Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity

James J. Gilchrist, Seiko Makino, Vivek Naranbhai, Piyush Kumar Sharma, Surya Koturan, Orion Tong, Chelsea Taylor, Robert Watson, Alba Verge de los Aires, Rosalin Cooper, Evelyn Lau, Sara Danielli, Dan Hameiri‐Bowen, Wanseon Lee, Esther Ng, Justin P. Whalley, Julian C. Knight, Benjamin P. Fairfax

2022Nature Communications35 citationsDOIOpen Access PDF

Abstract

Natural Killer cells are innate lymphocytes with central roles in immunosurveillance and are implicated in autoimmune pathogenesis. The degree to which regulatory variants affect Natural Killer cell gene expression is poorly understood. Here we perform expression quantitative trait locus mapping of negatively selected Natural Killer cells from a population of healthy Europeans (n = 245). We find a significant subset of genes demonstrate expression quantitative trait loci specific to Natural Killer cells and these are highly informative of human disease, in particular autoimmunity. A Natural Killer cell transcriptome-wide association study across five common autoimmune diseases identifies further novel associations at 27 genes. In addition to these cis observations, we find novel master-regulatory regions impacting expression of trans gene networks at regions including 19q13.4, the Killer cell Immunoglobulin-like Receptor region, GNLY, MC1R and UVSSA. Our findings provide new insights into the unique biology of Natural Killer cells, demonstrating markedly different expression quantitative trait loci from other immune cells, with implications for disease mechanisms.

Topics & Concepts

BiologyAutoimmunityExpression quantitative trait lociNatural killer cellTranscriptomeImmune systemImmunologyInnate immune systemImmunosurveillanceGeneQuantitative trait locusGeneticsGene expressionCytotoxic T cellGenotypeIn vitroSingle-nucleotide polymorphismImmune Cell Function and InteractionT-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways